Stopping high doses of domperidone, drug used for breastfeeding, can cause withdrawal, Health Canada warns
CBC
A Health Canada review has found there is a risk of psychiatric withdrawal effects when women using the drug domperidone to stimulate breast milk production suddenly stop taking it.
Health Canada will update the product monograph, or scientific description of a drug's properties "to note that cases of psychiatric withdrawal events have been reported," the regulator said in a statement posted on its Drug and Health Product Portal. It has also issued updated guidance to doctors and other health care providers informing them of the risk.
Domperidone is a gastrointestinal medication approved in Canada to speed up digestion at a recommended maximum dose of 30 mg per day. A CBC investigation in December 2022 found it is regularly prescribed at doses several times higher than that to help women produce breast milk, a purpose for which it has never been authorized in Canada.
Domperidone is also prescribed off-label for other reasons, including to stimulate lactation using doses typically three- to five-times higher than the approved gastrointestinal use. Of the nine cases reviewed by Health Canada, eight involved doses higher than 30 mg/day to stimulate lactation.
Women told CBC that when they stopped taking the drug, they experienced extreme anxiety, panic attacks, insomnia and intrusive thoughts so severe they were left unable to function or care for their children, often for months.
Some women were forced to stop working or move in with their parents. At least one attempted to take her own life.
Montreal resident Jamie Robinson experienced debilitating panic attacks and extreme anxiety when she stopped taking domperidone, eight months after the birth of her daughter. She recalls struggling to explain it to doctors, some of whom told her she had postpartum depression.
"I felt like there was so much difficulty in conveying the level of crisis that domperidone brought into my life that words like anxiety or depression … can't even begin to broach the intensity of the experience," she said.
Robinson's psychologist, Karen White, connected her sudden and severe reactions to stopping domperidone, which blocks dopamine in the brain and can act as an antipsychotic.
At home and mentally unable to work or care for her child, Robinson went looking for reports of similar reactions and found little in the way of medical guidance. But on social media, she found dozens of other mothers who had experienced similar symptoms when they stopped taking domperidone.
She compiled their experiences into a blog in the hope, she said, that other women would have the information about stopping the medication that she didn't.
Robinson also encouraged the women to report their symptoms to Health Canada's Adverse Reaction Online Database.
Two years later, a Health Canada review of the reports in that database and published case studies in other countries confirmed the link.
"Health Canada's review of available information found an association between abruptly discontinuing or tapering domperidone, used off-label for lactation stimulation, and psychiatric withdrawal events including, but not limited to, depression, anxiety and insomnia," the agency said in a statement to CBC. The review started in December 2022.
Toronto resident Winhan Wong's lung cancer journey began in 2016, with a nagging cough that just wouldn't go away.
Last month, Assembly of First Nations National Chief Cindy Woodhouse Nepinak pointed out on social media that history was made this year because there are a record 164 female chiefs serving across the country.
Most of humanity has a great propensity to think in the short-term, but generally, long-term considerations — air pollution, deforestation and emissions, for example — just aren't our thing.
As the COVID-19 pandemic began to unfold in early April 2020, Kolter Bouchard was just weeks into fatherhood when he noticed a lump on his neck.
Advocates and health care providers say they remain concerned about First Nations kids seeking services under Jordan's Principle even after the Canadian government’s recent promise of $1.55 billion in funding.
Contrary to science fiction, black holes are not portals to other dimensions or cosmic vacuum cleaners that swallow up everything around them.
An attempt to preserve files documenting some of the worst harms caused by Indian Residential Schools could soon head to Parliament.
A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and that many more would like to, but cost is a barrier.
For years, people living in Canada’s north have reported an increasing numbers of polar bears on shore, venturing into communities and encountering humans.
When Maureen Hayes first tested her Ottawa home for radon a little over a year ago, the initial reading was far below Canada's current threshold to take action.
Debate over legislation to update animal testing rules will resume next month, with one lawyer fearing it will end important research into cardio-vascular disease without proper debate.
Sam Pratt was around 13 when he first saw people talking about "looksmaxxing" on YouTube.
A group advocating on behalf of Indigenous people who cross the Canada-U.S. border says it’s disappointed by new travel advice from the federal government.